159 filings
Page 3 of 8
8-K/A
o5jdzfq4x1x9s
30 Jun 21
Annual General Meeting of
4:02pm
8-K
tk967c3ggv0spvy1l6pc
28 Jun 21
Annual General Meeting of
4:02pm
8-K
b1l emmc7d
25 Jun 21
Changes in Registrant's Certifying Accountant
4:02pm
10-Q
ynqldeutqzwf77i1g7w
22 Jun 21
Quarterly report
4:18pm
UPLOAD
6ac7ep8 1qkoneql9up1
18 May 21
Letter from SEC
12:00am
NT 10-Q
5xsanr7
17 May 21
Notice of late quarterly filing
4:15pm
S-1
p5b bivijd5
13 May 21
IPO registration
12:00am
8-K
4k9 n829xc
4 May 21
Todos Medical Receives FDA Certificate of Free Sale for New 5 Day Tollovid™ Dosing Regimen
3:07pm
RW
5afz2vd ejvuuol4
3 May 21
Registration withdrawal request
9:36pm
8-K
9n6cic
30 Apr 21
Entry into a Material Definitive Agreement
5:29pm
8-K
u2y6xmd2jzmy
23 Apr 21
Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa® Breast Cancer Blood Test
10:32am
10-K
9whaxq eg
21 Apr 21
Annual report
5:31pm
8-K
60zhz45
14 Apr 21
Entry into a Material Definitive Agreement
3:04pm
NT 10-K
r6s41had01k9cywl
1 Apr 21
Notice of late annual filing
12:00am
8-K
kemozvuystey 346c
22 Mar 21
Entry into a Material Definitive Agreement
10:29am
8-K
w0dw0ng9bndwpz2psbl7
12 Mar 21
Entry into a Material Definitive Agreement
9:51am
8-K
pdwu6f9tuu
26 Jan 21
Todos Medical Announces Strategic Investment by Yozma Group Korea
5:28pm
6-K
k9ebv2ns2dh4ebhizh
15 Dec 20
Current report (foreign)
3:00pm
424B4
4rgfv d9fa5
20 Aug 20
Prospectus supplement with pricing info
12:00am
EFFECT
zautqa9h oeuhmoew
19 Aug 20
Notice of effectiveness
12:15am